Philip Hughes

Fasnall, a Selective FASN Inhibitor, Shows Potent Anti-tumor Activity in the MMTV-Neu Model of HER2(+) Breast Cancer.

Timothy A J Haystead, Laura G. Dubois, Philip F. Hughes, 2016, Cell chemical biology.